SDS Optic develops and creates innovative solutions on the borderline of biochemistry, engineering and fibre optic technologies, that can be used in cancer diagnosis and treatment. Company designed a revolutionary opto-biological methodology that allows for instant cellular processes studies including in-vivo cancer diagnosis with single-cell resolution. inPROBE detects presence and measures concentration levels of the HER+ cancer cells in breast tumours.
The SDS Optic team is working on a breakthrough technology based on rapid detection of the test substance in the body, including cancer markers, with particular accuracy, the use of laser beams and the use of innovative components. At the end of the process, the reading is interpreted on the detector using an appropriate conversion algorithm, which gives the level of the tested compound (e.g. HER2 cancer marker) in a numerical form.
Our technology is a breakthrough. We create inPROBE a tool for direct measurement of the HER2 marker. The use of a microsonde will save the patient pain and stress associated with biopsy and waiting for the result. We want to save up to 30% of people diagnosed with cancer by year 2030
